Skip to Main Content

Author Details

Pajaree Chariyavilaskul
Chulalongkorn University
2013
40
10
PMIDPaper TitleJournal TitlePublished Year
36671328The In Vitro Efficacy of Activated Charcoal in Fecal Ceftriaxone Adsorption among Patients Who Received Intravenous Ceftriaxone.Antibiotics (Basel)2023
35194061The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration.Sci Rep2022
35842213Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study.Int J Infect Dis2022
35370416Association Between Indoxyl Sulfate and Dialysis Initiation and Cardiac Outcomes in Chronic Kidney Disease Patients.Int J Nephrol Renovasc Dis2022
35570339Pharmacokinetics and pharmacodynamics profiles of enteric-coated mycophenolate sodium in female patients with difficult-to-treat lupus nephritis.Clin Transl Sci2022
35531138A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose.Res Pharm Sci2022
35868608Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection.Int J Infect Dis2022
36327219Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.PLoS Genet2022
35013560Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population.J Hum Genet2022
35279655Comparative Effectiveness between Expanded Hemodialysis (Hemodialysis Using a Medium Cut-Off Dialyzer) and Mixed-Dilution Online Hemodiafiltration Using a High-Flux Dialyzer in Removing Middle-Molecule Uremic Toxins.Blood Purif2022
35210819Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia.Pharmgenomics Pers Med2022
35176049Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population.PLoS One2022
35028951Comparative efficacy between hemodialysis using super high-flux dialyzer with hemoperfusion and high-volume postdilution online hemodiafiltration in removing protein bound and middle molecule uremic toxins: A cross-over randomized controlled trial.Artif Organs2022
32356365Super high-flux hemodialysis provides comparable effectiveness with high-volume postdilution online hemodiafiltration in removing protein-bound and middle-molecule uremic toxins: A prospective cross-over randomized controlled trial.Ther Apher Dial2021
33767223Pharmacokinetics and metabolomics investigation of an orally modified formula of standardized Centella asiatica extract in healthy volunteers.Sci Rep2021
33577615Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.PLoS One2021
34603040Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach.Front Pharmacol2021
34678981Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial.Toxins (Basel)2021
34335044Influence of <i>SULT1A1*2</i> Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients.Pharmgenomics Pers Med2021
34108605Publisher Correction: Pharmacokinetics and metabolomics investigation of an orally modified formula of standardized Centella asiatica extract in healthy volunteers.Sci Rep2021
32179149Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.Int J Antimicrob Agents2020
32021383Pharmacogene Variation in Thai <i>Plasmodium vivax</i> Relapse Patients Treated with a Combination of Primaquine and Chloroquine.Pharmgenomics Pers Med2020
32063189Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.Perit Dial Int2020
33144648Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.Sci Rep2020
33425706Development and validation of an ultra-performance liquid chromatography mass spectrometry/mass spectrometry method for simultaneous quantification of total and free mycophenolic acid and its metabolites in human plasma.J Adv Pharm Technol Res2020
33177862CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia.Pharmgenomics Pers Med2020
33122935<i>SLCO1B1</i> and <i>ABCG2</i> Gene Polymorphisms in a Thai Population.Pharmgenomics Pers Med2020
30699457Safety and Pharmacokinetics of Standardized Extract of Centella asiatica (ECa 233) Capsules in Healthy Thai Volunteers: A Phase 1 Clinical Study.Planta Med2019
30991873The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison.Ren Fail2019
29539600The Cytochrome P450 3A5 Non-Expressor Kidney Allograft as a Risk Factor for Calcineurin Inhibitor Nephrotoxicity.Am J Nephrol2018
27738089Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.Perit Dial Int2017
29092730Bioequivalence and pharmacokinetic/pharmacodynamic correlation of clopidogrel in healthy Thai subjects⿩.Int J Clin Pharmacol Ther2017
28513426Pharmacokinetics and bioequivalence of a pregabalin 150-mg capsule in healthy Thai subjects.Int J Clin Pharmacol Ther2017
25588323In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.Urolithiasis2015
26518946A Simple Novel Technique to Estimate Tacrolimus Dosages During the Early Post Kidney Transplantation Period.Transplant Proc2015
25764607A reduction of asymmetric dimethylarginine in renal transplant recipients receiving sirolimus-based regimen.J Med Assoc Thai2015
25801761Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.J Am Heart Assoc2015
25424003Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease.J Lipid Res2015
24725445Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.Int J Clin Pharmacol Ther2014
23651860Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis.Lupus2013
  • 1 - 40 of 40

Recommended Authors

Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 0
Nationwide Children's Hospital, College of Medicine, The Ohio State University
Career Start Year 2008
Number of shared co-authors 0
Institute of Genetic Epidemiology, University of Freiburg
Career Start Year 2008
Number of shared co-authors 0
School of Pharmacy, Shiraz University of Medical Sciences
Career Start Year 2007
Number of shared co-authors 0
Amunix Pharmaceuticals
Career Start Year 2006
Number of shared co-authors 0
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Career Start Year 2005
Number of shared co-authors 0
Collegeville
Career Start Year 2004
Number of shared co-authors 0
Stanford University
Career Start Year 2004
Number of shared co-authors 2
Clinical Development
Career Start Year 2003
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 0
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 1
University of Pittsburgh School of Pharmacy
Career Start Year 2002
Number of shared co-authors 0
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 0
Seoul National University Bundang Hospital and College of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 0
Yonsei University College of Medicine, Severance Hospital
Career Start Year 1998
Number of shared co-authors 0
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year 1998
Number of shared co-authors 1
University of Pennsylvania Perelman School of Medicine
Career Start Year 1996
Number of shared co-authors 1
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 1
Western University
Career Start Year 1996
Number of shared co-authors 1
Faculty of Pharmacy, Suez Canal University
Career Start Year 1995
Number of shared co-authors 1
University of Pennsylvania.
Career Start Year 1995
Number of shared co-authors 1
Universite Paris Saclay
Career Start Year 1994
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 2
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 1
University of Louisville
Career Start Year 1991
Number of shared co-authors 0
UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill
Career Start Year 1984
Number of shared co-authors 2
Cincinnati Children's Hospital Medical Center
Career Start Year 1982
Number of shared co-authors 0
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 0

Collaborators

Chulalongkorn University
Co-authored papers 7
Chulalongkorn University
Co-authored papers 4
Chulalongkorn University
Co-authored papers 4
King Chulalongkorn Memorial Hospital, Chulalongkorn University
Co-authored papers 3
Chulalongkorn University
Co-authored papers 3
Chulalongkorn University
Co-authored papers 2
Chulalongkorn University
Co-authored papers 2
Chulalongkorn University and King Chulalongkorn Memorial Hospital
Co-authored papers 2
Co-authored papers 1
King Fahad Medical City and King Abdulaziz City for Science and Technology
Co-authored papers 1
Keio University School of Medicine
Co-authored papers 1
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Icahn School of Medicine at Mount Sinai.
Co-authored papers 1
Instituto de Investigacion Sanitaria de Santiago
Co-authored papers 1
David Geffen School of Medicine, University of California-Los Angeles
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
MNM Bioscience Inc.
Co-authored papers 1
Uppsala University
Co-authored papers 1
The Rockefeller University
Co-authored papers 1
Co-authored papers 1
King Fahad Medical City and King Abdulaziz City for Science and Technology
Co-authored papers 1
Osaka University Graduate School of Medicine
Co-authored papers 1
Institute of Medical Genetics and Applied Genomics, University of Tuebingen
Co-authored papers 1
Medical University of Gdansk
Co-authored papers 1
McGill University
Co-authored papers 1